prikaz prve stranice dokumenta Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
  Download
PDF 614.83 KB
Scientific paper - Original scientific paper
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
Acta clinica Croatica, 60. (2021), Supplement 2; 36-52. https://doi.org/10.20471/acc.2021.60.s1.03
Virović Jukić, Lucija; Grgurević, Ivica; Mikolašević, Ivana; Filipec Kanižaj, Tajana; Milić, Sandra; Mrzljak, Anna; Premužić, Marina; Hrstić, Irena; Knežević Štromar, Ivana; Ljubičić, Neven; Ostojić, Rajko; Stojsavljević Shapeski, Sanja; Amerl-Šakić, Vjekoslava; Bašić Marković, Nina; Rađa, Marko; Soldo, Dragan; Sobočan, Nikola; Lalovac, Miloš; Puljiz, Željko; Podrug, Kristian; Ladić, Dinko More authors...

Cite this document

Virović Jukić, L., Grgurević, I., Mikolašević, I., Filipec Kanižaj, T., Milić, S., Mrzljak, A. ... Ladić, D. (2021). Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease. Acta clinica Croatica, 60.. (Supplement 2), 36-52. doi: 10.20471/acc.2021.60.s1.03

Virović Jukić, Lucija, et al. "Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease." Acta clinica Croatica, vol. 60., no. Supplement 2, 2021, pp. 36-52. https://doi.org/10.20471/acc.2021.60.s1.03

Virović Jukić, Lucija, Ivica Grgurević, Ivana Mikolašević, Tajana Filipec Kanižaj, Sandra Milić, Anna Mrzljak, Marina Premužić, et al. "Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease." Acta clinica Croatica 60., no. Supplement 2 (2021): 36-52. https://doi.org/10.20471/acc.2021.60.s1.03

Virović Jukić, L., et al. (2021) 'Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease', Acta clinica Croatica, 60.(Supplement 2), pp. 36-52. doi: 10.20471/acc.2021.60.s1.03

Virović Jukić L, Grgurević I, Mikolašević I, Filipec Kanižaj T, Milić S, Mrzljak A, and sur.. Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease. Acta clinica Croatica [Internet]. 2021 [cited 2024 November 27];60.(Supplement 2):36-52. doi: 10.20471/acc.2021.60.s1.03

L. Virović Jukić, et al., "Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease", Acta clinica Croatica, vol. 60., no. Supplement 2, pp. 36-52, 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:119870. [Accessed: 27 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
AuthorLucija Virović Jukić
AuthorIvica Grgurević
AuthorIvana Mikolašević
AuthorTajana Filipec Kanižaj
AuthorSandra Milić
AuthorAnna Mrzljak
AuthorMarina Premužić
AuthorIrena Hrstić
AuthorIvana Knežević Štromar
AuthorNeven Ljubičić
AuthorRajko Ostojić
AuthorSanja Stojsavljević Shapeski
AuthorVjekoslava Amerl-Šakić
AuthorNina Bašić Marković
AuthorMarko Rađa
AuthorDragan Soldo
AuthorNikola Sobočan
AuthorMiloš Lalovac
AuthorŽeljko Puljiz
AuthorKristian Podrug
AuthorDinko Ladić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Nonalcoholic fatty liver disease (NAFLD) is a term describing excessive accumulation of fat in hepatocytes, and is associated with metabolic syndrome and insulin resistance. NAFLD prevalence is on increase and goes in parallel with the increasing prevalence of metabolic syndrome and its components. That is why Croatian guidelines have been developed, which cover the screening protocol for patients with NAFLD risk factors, and the recommended diagnostic work-up and treatment of NAFLD patients. NAFLD screening should be done in patients with type 2 diabetes mellitus, or persons with two or more risk factors as part of metabolic screening, and is carried out by noninvasive laboratory and imaging methods used to detect fibrosis. Patient work-up should exclude the existence of other causes of liver injury and determine the stage of fibrosis as the most important factor in disease prognosis. Patients with initial stages of fibrosis continue to be monitored at the primary healthcare level with the management of metabolic risk factors, dietary measures, and increased physical activity. Patients with advanced fibrosis should be referred to a gastroenterologist/ hepatologist for further treatment, monitoring, and detection and management of complications.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleActa clinica Croatica
Numberingvol. 60., no. Supplement 2, pp. 36-52
p-ISSN0353-9466
e-ISSN1333-9451
DOIhttps://doi.org/10.20471/acc.2021.60.s1.03
URN:NBNurn:nbn:hr:184:119870
Publication2021
Document URLhttps://hrcak.srce.hr/275610
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2022-04-27 11:08:41